Global Medical Heparin Industry Research & Trends Analysis Report
According to Latest Study, the global market for Medical Heparin should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
China Medical Heparin market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
The United States Medical Heparin market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
In terms of molecular weight, High Molecular Weight Heparin (HMWH) segment holds a share about % in 2024 and will reach % in 2030; while in terms of application, Treatment of Thrombotic Diseases has a share approximately % in 2023 and will grow at a CAGR % during 2024 and 2030.
The global key manufacturers of Medical Heparin include Hepalink, Changshan Pharm, Pfizer, Bioberica, Criticine Care, SmithField BioScience, Sanofi, Fresenius Kabi and Aspen Pharmacare, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
Heparin is an anticoagulant drug commonly used to prevent and treat thrombotic diseases. It is a natural polysaccharide substance secreted by liver cells and lung cells, which has the effect of inhibiting thrombin and preventing blood from clotting in blood vessels.
Heparin is usually administered by intravenous or subcutaneous injection. It is widely used in cardiac surgery, hemodialysis, treatment of thrombotic diseases, and other situations that require anticoagulation. Unlike other anticoagulants, the effect of heparin is reversible, which makes it very useful in situations where anticoagulation needs to be quickly stopped, such as during surgery.
However, the use of heparin also carries some risks, such as bleeding and other side effects. Therefore, before using heparin, doctors will assess the risks and benefits based on the patient's specific condition and develop a personalized treatment plan.
This report aims to provide a comprehensive study of the global market for Medical Heparin. Report Highlights:
(1) Global Medical Heparin market size (sales volume & revenue), history data from 2019-2023 and forecast data from 2024 to 2030.
(2) Global Medical Heparin market competitive situation, sales, revenue, price and market share, from 2019 to 2023.
(3) China Medical Heparin market competitive situation, sales, revenue, price and market share, from 2019 to 2023.
(4) Global Medical Heparin segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Medical Heparin segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Medical Heparin, capacity, production and trends.
(7) Medical Heparin industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by molecular weight, covers
High Molecular Weight Heparin (HMWH)
Low Molecular Weight Heparin (LMWH)
Market segment by application, can be divided into
Treatment of Thrombotic Diseases
Postoperative Rehabilitation
Others
Market segment by players, this report covers
Hepalink
Changshan Pharm
Pfizer
Bioberica
Criticine Care
SmithField BioScience
Sanofi
Fresenius Kabi
Aspen Pharmacare
LEO Pharma
Baxter Healthcare
Cardinal Health
SwissPAR
Fierce Pharma
1 Market Overview
1.1 Medical Heparin Definition
1.2 Global Medical Heparin Market Size and Forecast
1.2.1 By Revenue, Global Medical Heparin Market Size, 2019-2030
1.2.2 By Sales Volume, Global Medical Heparin Market Size, 2019-2030
1.2.3 Global Medical Heparin Price Trend, 2019-2030
1.3 China Medical Heparin Market Size and Forecast
1.3.1 By Revenue, China Medical Heparin Market Size, 2019-2030
1.3.2 By Sales Volume, China Medical Heparin Market Size, 2019-2030
1.3.3 China Medical Heparin Price Trend, 2019-2030
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Medical Heparin Share in Global Market, 2019-2030
1.4.2 By Sales Volume, China Medical Heparin Share in Global Market, 2019-2030
1.4.3 Medical Heparin Market Size: China VS Global, 2019-2030
1.5 Medical Heparin Market Dynamics
1.5.1 Medical Heparin Market Drivers
1.5.2 Medical Heparin Market Restraints
1.5.3 Medical Heparin Industry Trends
1.5.4 Medical Heparin Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Medical Heparin Revenue by Company, 2019-2024
2.2 Global Medical Heparin Sales Volume by Company, 2019-2024
2.3 Global Medical Heparin Price by Company, 2019-2024
2.4 Global Medical Heparin Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Medical Heparin Concentration Ratio
2.6 Global Medical Heparin Mergers & Acquisitions, Expansion Plans
2.7 Global Medical Heparin Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Medical Heparin Revenue by Company, 2019-2024
3.2 China Medical Heparin Sales Volume by Company, 2019-2024
3.3 China Medical Heparin Medical Heparin Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Medical Heparin Market, Sales Percentage of Local Players VS Foreign Players (2019-2024)
3.5 Chinese Local Players, Medical Heparin Domestic VS Export
3.6 China Market, Medical Heparin Import & Export
3.6.1 China Market, Medical Heparin Import & Export, 2019-2030
3.6.2 China Medical Heparin Import & Export Trends
3.6.3 Main Sources of China Medical Heparin Import
3.6.4 Export Destination of China Medical Heparin
4 Medical Heparin Production by Region
4.1 Global Medical Heparin Capacity, Production and Capacity Utilization, 2019-2030
4.2 Global Geographic Distribution of Medical Heparin Manufacturers
4.3 Global Major Manufacturers, Medical Heparin Capacity Expansion and Future Plans
4.4 Global Medical Heparin Capacity by Region
4.5 Global Medical Heparin Production by Region
4.5.1 Global Medical Heparin Production & Forecast by Region, 2019 VS 2024 VS 2030
4.5.2 Global Medical Heparin Production by Region, 2019-2024
4.5.3 Global Medical Heparin Production Market Share & Forecast by Region, 2019-2030
5 Industry Chain Analysis
5.1 Medical Heparin Industry Chain
5.2 Medical Heparin Upstream Analysis
5.2.1 Medical Heparin Core Raw Materials
5.2.2 Main Manufacturers of Medical Heparin Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Medical Heparin Production Mode
5.6 Medical Heparin Procurement Model
5.7 Medical Heparin Industry Sales Model and Sales Channels
5.7.1 Medical Heparin Sales Model
5.7.2 Medical Heparin Typical Distributors
6 Sights by Molecular Weight
6.1 Medical Heparin Classification
6.1.1 High Molecular Weight Heparin (HMWH)
6.1.2 Low Molecular Weight Heparin (LMWH)
6.2 By Molecular Weight, Global Medical Heparin Market Size & CAGR, 2019 VS 2024 VS 2030
6.3 By Molecular Weight, Global Medical Heparin Revenue, 2019-2030
6.4 By Molecular Weight, Global Medical Heparin Sales Volume, 2019-2030
6.5 By Molecular Weight, Global Medical Heparin Price, 2019-2030
7 Sights by Application
7.1 Medical Heparin Segment by Application
7.1.1 Treatment of Thrombotic Diseases
7.1.2 Postoperative Rehabilitation
7.1.3 Others
7.2 By Application, Global Medical Heparin Market Size & CAGR, 2019 VS 2024 VS 2030
7.3 By Application, Global Medical Heparin Revenue, 2019-2030
7.4 By Application, Global Medical Heparin Sales Volume, 2019-2030
7.5 By Application, Global Medical Heparin Price, 2019-2030
8 Sales Sights by Region
8.1 By Region, Global Medical Heparin Market Size, 2019 VS 2024 VS 2030
8.2 By Region, Global Medical Heparin Revenue, 2019-2030
8.3 By Region, Global Medical Heparin Sales Volume, 2019-2030
8.4 North America
8.4.1 North America Medical Heparin Market Size & Forecasts, 2019-2030
8.4.2 By Country, North America Medical Heparin Market Size Market Share
8.5 Europe
8.5.1 Europe Medical Heparin Market Size & Forecasts, 2019-2030
8.5.2 By Country, Europe Medical Heparin Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Medical Heparin Market Size & Forecasts, 2019-2030
8.6.2 By Country/Region, Asia Pacific Medical Heparin Market Size Market Share
8.7 South America
8.7.1 South America Medical Heparin Market Size & Forecasts, 2019-2030
8.7.2 By Country, South America Medical Heparin Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Medical Heparin Market Size & CAGR，2019 VS 2024 VS 2030
9.2 By Country, Global Medical Heparin Revenue, 2019-2030
9.3 By Country, Global Medical Heparin Sales Volume, 2019-2030
9.4 U.S.
9.4.1 U.S. Medical Heparin Market Size, 2019-2030
9.4.2 By Company, U.S. Medical Heparin Sales Volume Market Share, 2022
9.4.3 By Molecular Weight, U.S. Medical Heparin Market Size, Share, 2022 VS 2029
9.4.4 By Application, U.S. Medical Heparin Market Size, Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Medical Heparin Market Size, 2019-2030
9.5.2 By Company, Europe Medical Heparin Sales Volume Market Share, 2022
9.5.3 By Molecular Weight, Europe Medical Heparin Market Size, Share, 2022 VS 2029
9.5.4 By Application, Europe Medical Heparin Market Size, Share, 2022 VS 2029
9.6 China
9.6.1 China Medical Heparin Market Size, 2019-2030
9.6.2 By Company, China Medical Heparin Sales Volume Market Share, 2022
9.6.3 By Molecular Weight, China Medical Heparin Market Size, Share, 2022 VS 2029
9.6.4 By Application, China Medical Heparin Market Size, Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Medical Heparin Market Size, 2019-2030
9.7.2 By Company, Japan Medical Heparin Sales Volume Market Share, 2022
9.7.3 By Molecular Weight, Japan Medical Heparin Market Size, Share, 2022 VS 2029
9.7.4 By Application, Japan Medical Heparin Market Size, Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Medical Heparin Market Size, 2019-2030
9.8.2 By Company, South Korea Medical Heparin Sales Volume Market Share, 2022
9.8.3 By Molecular Weight, South Korea Medical Heparin Market Size, Share, 2022 VS 2029
9.8.4 By Application, South Korea Medical Heparin Market Size, Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Medical Heparin Market Size, 2019-2030
9.9.2 By Company, Southeast Asia Medical Heparin Sales Volume Market Share, 2022
9.9.3 By Molecular Weight, Southeast Asia Medical Heparin Market Size, Share, 2022 VS 2029
9.9.4 By Application, Southeast Asia Medical Heparin Market Size, Share, 2022 VS 2029
9.10 India
9.10.1 India Medical Heparin Market Size, 2019-2030
9.10.2 By Company, India Medical Heparin Sales Volume Market Share, 2022
9.10.3 By Molecular Weight, India Medical Heparin Market Size, Share, 2022 VS 2029
9.10.4 By Application, India Medical Heparin Market Size, Share, 2022 VS 2029
9.11 Middle East & Asia
9.11.1 Middle East & Asia Medical Heparin Market Size, 2019-2030
9.11.2 By Company, Middle East & Asia Medical Heparin Sales Volume Market Share, 2022
9.11.3 By Molecular Weight, Middle East & Asia Medical Heparin Market Size, Share, 2022 VS 2029
9.11.4 By Application, Middle East & Asia Medical Heparin Market Size, Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Hepalink
10.1.1 Hepalink Company Information, Head Office, Market Area and Industry Position
10.1.2 Hepalink Medical Heparin Models, Specifications and Application
10.1.3 Hepalink Medical Heparin Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.1.4 Hepalink Company Profile and Main Business
10.1.5 Hepalink Recent Developments
10.2 Changshan Pharm
10.2.1 Changshan Pharm Company Information, Head Office, Market Area and Industry Position
10.2.2 Changshan Pharm Medical Heparin Models, Specifications and Application
10.2.3 Changshan Pharm Medical Heparin Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.2.4 Changshan Pharm Company Profile and Main Business
10.2.5 Changshan Pharm Recent Developments
10.3 Pfizer
10.3.1 Pfizer Company Information, Head Office, Market Area and Industry Position
10.3.2 Pfizer Medical Heparin Models, Specifications and Application
10.3.3 Pfizer Medical Heparin Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.3.4 Pfizer Company Profile and Main Business
10.3.5 Pfizer Recent Developments
10.4 Bioberica
10.4.1 Bioberica Company Information, Head Office, Market Area and Industry Position
10.4.2 Bioberica Medical Heparin Models, Specifications and Application
10.4.3 Bioberica Medical Heparin Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.4.4 Bioberica Company Profile and Main Business
10.4.5 Bioberica Recent Developments
10.5 Criticine Care
10.5.1 Criticine Care Company Information, Head Office, Market Area and Industry Position
10.5.2 Criticine Care Medical Heparin Models, Specifications and Application
10.5.3 Criticine Care Medical Heparin Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.5.4 Criticine Care Company Profile and Main Business
10.5.5 Criticine Care Recent Developments
10.6 SmithField BioScience
10.6.1 SmithField BioScience Company Information, Head Office, Market Area and Industry Position
10.6.2 SmithField BioScience Medical Heparin Models, Specifications and Application
10.6.3 SmithField BioScience Medical Heparin Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.6.4 SmithField BioScience Company Profile and Main Business
10.6.5 SmithField BioScience Recent Developments
10.7 Sanofi
10.7.1 Sanofi Company Information, Head Office, Market Area and Industry Position
10.7.2 Sanofi Medical Heparin Models, Specifications and Application
10.7.3 Sanofi Medical Heparin Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.7.4 Sanofi Company Profile and Main Business
10.7.5 Sanofi Recent Developments
10.8 Fresenius Kabi
10.8.1 Fresenius Kabi Company Information, Head Office, Market Area and Industry Position
10.8.2 Fresenius Kabi Medical Heparin Models, Specifications and Application
10.8.3 Fresenius Kabi Medical Heparin Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.8.4 Fresenius Kabi Company Profile and Main Business
10.8.5 Fresenius Kabi Recent Developments
10.9 Aspen Pharmacare
10.9.1 Aspen Pharmacare Company Information, Head Office, Market Area and Industry Position
10.9.2 Aspen Pharmacare Medical Heparin Models, Specifications and Application
10.9.3 Aspen Pharmacare Medical Heparin Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.9.4 Aspen Pharmacare Company Profile and Main Business
10.9.5 Aspen Pharmacare Recent Developments
10.10 LEO Pharma
10.10.1 LEO Pharma Company Information, Head Office, Market Area and Industry Position
10.10.2 LEO Pharma Medical Heparin Models, Specifications and Application
10.10.3 LEO Pharma Medical Heparin Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.10.4 LEO Pharma Company Profile and Main Business
10.10.5 LEO Pharma Recent Developments
10.11 Baxter Healthcare
10.11.1 Baxter Healthcare Company Information, Head Office, Market Area and Industry Position
10.11.2 Baxter Healthcare Medical Heparin Models, Specifications and Application
10.11.3 Baxter Healthcare Medical Heparin Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.11.4 Baxter Healthcare Company Profile and Main Business
10.11.5 Baxter Healthcare Recent Developments
10.12 Cardinal Health
10.12.1 Cardinal Health Company Information, Head Office, Market Area and Industry Position
10.12.2 Cardinal Health Medical Heparin Models, Specifications and Application
10.12.3 Cardinal Health Medical Heparin Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.12.4 Cardinal Health Company Profile and Main Business
10.12.5 Cardinal Health Recent Developments
10.13 SwissPAR
10.13.1 SwissPAR Company Information, Head Office, Market Area and Industry Position
10.13.2 SwissPAR Medical Heparin Models, Specifications and Application
10.13.3 SwissPAR Medical Heparin Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.13.4 SwissPAR Company Profile and Main Business
10.13.5 SwissPAR Recent Developments
10.14 Fierce Pharma
10.14.1 Fierce Pharma Company Information, Head Office, Market Area and Industry Position
10.14.2 Fierce Pharma Medical Heparin Models, Specifications and Application
10.14.3 Fierce Pharma Medical Heparin Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.14.4 Fierce Pharma Company Profile and Main Business
10.14.5 Fierce Pharma Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Medical Heparin Market Size & CAGR: China VS Global, 2019-2030, US$ Million
Table 2. Medical Heparin Market Restraints
Table 3. Medical Heparin Market Trends
Table 4. Medical Heparin Industry Policy
Table 5. Global Medical Heparin Revenue by Company, 2019-2024, US$ million
Table 6. Global Medical Heparin Revenue Market Share by Company, 2019-2024
Table 7. Global Medical Heparin Sales Volume by Company, 2019-2024, (Tons)
Table 8. Global Medical Heparin Sales Volume Market Share by Company, 2019-2024
Table 9. Global Medical Heparin Price by Company, 2019-2024, (US$/Ton)
Table 10. Global Medical Heparin Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Medical Heparin Mergers & Acquisitions, Expansion Plans
Table 12. Global Medical Heparin Manufacturers Product Type
Table 13. China Medical Heparin Revenue by Company, 2019-2024, US$ million
Table 14. China Medical Heparin Revenue Market Share by Company, 2019-2024
Table 15. China Medical Heparin Sales Volume by Company, 2019-2024, (Tons)
Table 16. China Medical Heparin Sales Volume Market Share by Company, 2019-2024
Table 17. China Market, Medical Heparin Production, Sales, Import and Export, 2019-2030, (Tons)
Table 18. China Medical Heparin Import & Export Trends
Table 19. Main Sources of China Medical Heparin Import
Table 20. Export Destination of China Medical Heparin
Table 21. Global Headquarters and Manufacturing Base of Medical Heparin Manufacturers
Table 22. Global Major Manufacturers, Medical Heparin Capacity Expansion and Future Plans
Table 23. Global Medical Heparin Production & Forecast by Region, 2019 VS 2024 VS 2030, (Tons)
Table 24. Global Medical Heparin Production by Region, 2019-2024, (Tons)
Table 25. Global Medical Heparin Production Forecast by Region, 2024-2030, (Tons)
Table 26. Global Key Players of Medical Heparin Upstream (Raw Materials)
Table 27. Global Medical Heparin Typical Customers
Table 28. Medical Heparin Typical Distributors
Table 29. By Molecular Weight, Global Medical Heparin Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million
Table 30. By Application, Global Medical Heparin Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million
Table 31. By Region, Global Medical Heparin Market Size, 2019 VS 2024 VS 2030, US$ Million
Table 32. By Region, Global Medical Heparin Revenue, 2019-2030, US$ Million
Table 33. By Region, Global Medical Heparin Sales Volume, 2019-2030, (Tons)
Table 34. By Country, Global Medical Heparin Revenue & CAGR，2019 VS 2024 VS 2030, US$ Million
Table 35. By Country, Global Medical Heparin Revenue, 2019-2030, US$ Million
Table 36. By Country, Global Medical Heparin Revenue Market Share, 2019-2030
Table 37. By Country, Global Medical Heparin Sales Volume, 2019-2030, (Tons)
Table 38. By Country, Global Medical Heparin Sales Volume Market Share, 2019-2030
Table 39. Hepalink Company Information, Head Office, Market Area and Industry Position
Table 40. Hepalink Medical Heparin Models, Specifications and Application
Table 41. Hepalink Medical Heparin Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2019-2024
Table 42. Hepalink Company Profile and Main Business
Table 43. Hepalink Recent Developments
Table 44. Changshan Pharm Company Information, Head Office, Market Area and Industry Position
Table 45. Changshan Pharm Medical Heparin Models, Specifications and Application
Table 46. Changshan Pharm Medical Heparin Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2019-2024
Table 47. Changshan Pharm Company Profile and Main Business
Table 48. Changshan Pharm Recent Developments
Table 49. Pfizer Company Information, Head Office, Market Area and Industry Position
Table 50. Pfizer Medical Heparin Models, Specifications and Application
Table 51. Pfizer Medical Heparin Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2019-2024
Table 52. Pfizer Company Profile and Main Business
Table 53. Pfizer Recent Developments
Table 54. Bioberica Company Information, Head Office, Market Area and Industry Position
Table 55. Bioberica Medical Heparin Models, Specifications and Application
Table 56. Bioberica Medical Heparin Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2019-2024
Table 57. Bioberica Company Profile and Main Business
Table 58. Bioberica Recent Developments
Table 59. Criticine Care Company Information, Head Office, Market Area and Industry Position
Table 60. Criticine Care Medical Heparin Models, Specifications and Application
Table 61. Criticine Care Medical Heparin Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2019-2024
Table 62. Criticine Care Company Profile and Main Business
Table 63. Criticine Care Recent Developments
Table 64. SmithField BioScience Company Information, Head Office, Market Area and Industry Position
Table 65. SmithField BioScience Medical Heparin Models, Specifications and Application
Table 66. SmithField BioScience Medical Heparin Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2019-2024
Table 67. SmithField BioScience Company Profile and Main Business
Table 68. SmithField BioScience Recent Developments
Table 69. Sanofi Company Information, Head Office, Market Area and Industry Position
Table 70. Sanofi Medical Heparin Models, Specifications and Application
Table 71. Sanofi Medical Heparin Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2019-2024
Table 72. Sanofi Company Profile and Main Business
Table 73. Sanofi Recent Developments
Table 74. Fresenius Kabi Company Information, Head Office, Market Area and Industry Position
Table 75. Fresenius Kabi Medical Heparin Models, Specifications and Application
Table 76. Fresenius Kabi Medical Heparin Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2019-2024
Table 77. Fresenius Kabi Company Profile and Main Business
Table 78. Fresenius Kabi Recent Developments
Table 79. Aspen Pharmacare Company Information, Head Office, Market Area and Industry Position
Table 80. Aspen Pharmacare Medical Heparin Models, Specifications and Application
Table 81. Aspen Pharmacare Medical Heparin Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2019-2024
Table 82. Aspen Pharmacare Company Profile and Main Business
Table 83. Aspen Pharmacare Recent Developments
Table 84. LEO Pharma Company Information, Head Office, Market Area and Industry Position
Table 85. LEO Pharma Medical Heparin Models, Specifications and Application
Table 86. LEO Pharma Medical Heparin Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2019-2024
Table 87. LEO Pharma Company Profile and Main Business
Table 88. LEO Pharma Recent Developments
Table 89. Baxter Healthcare Company Information, Head Office, Market Area and Industry Position
Table 90. Baxter Healthcare Medical Heparin Models, Specifications and Application
Table 91. Baxter Healthcare Medical Heparin Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2019-2024
Table 92. Baxter Healthcare Company Profile and Main Business
Table 93. Baxter Healthcare Recent Developments
Table 94. Cardinal Health Company Information, Head Office, Market Area and Industry Position
Table 95. Cardinal Health Medical Heparin Models, Specifications and Application
Table 96. Cardinal Health Medical Heparin Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2019-2024
Table 97. Cardinal Health Company Profile and Main Business
Table 98. Cardinal Health Recent Developments
Table 99. SwissPAR Company Information, Head Office, Market Area and Industry Position
Table 100. SwissPAR Medical Heparin Models, Specifications and Application
Table 101. SwissPAR Medical Heparin Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2019-2024
Table 102. SwissPAR Company Profile and Main Business
Table 103. SwissPAR Recent Developments
Table 104. Fierce Pharma Company Information, Head Office, Market Area and Industry Position
Table 105. Fierce Pharma Medical Heparin Models, Specifications and Application
Table 106. Fierce Pharma Medical Heparin Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2019-2024
Table 107. Fierce Pharma Company Profile and Main Business
Table 108. Fierce Pharma Recent Developments
List of Figure
Figure 1. Medical Heparin Picture
Figure 2. By Revenue, Global Medical Heparin Market Size and Forecast, 2019-2030, US$ Million
Figure 3. By Sales Volume, Global Medical Heparin Market Size and Forecast, 2019-2030, (Tons)
Figure 4. Global Medical Heparin Price Trend, 2019-2030, (US$/Ton)
Figure 5. By Revenue, China Medical Heparin Market Size and Forecast, 2019-2030, US$ million
Figure 6. By Sales Volume, China Medical Heparin Market Size and Forecast, 2019-2030, (Tons)
Figure 7. China Medical Heparin Price Trend, 2019-2030 (US$/Ton)
Figure 8. By Revenue, China Medical Heparin Share of Global Market, 2019-2030
Figure 9. By Sales Volume, China Medical Heparin Share of Global Market, 2019-2030
Figure 10. Global Medical Heparin Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 11. Global Medical Heparin Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022
Figure 12. China Medical Heparin Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 13. China Medical Heparin Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 14. China Medical Heparin Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2019-2024
Figure 15. Chinese Local Players, Proportion of Medical Heparin Domestic VS Export, 2022
Figure 16. Global Medical Heparin Capacity, Production and Capacity Utilization, 2019-2030
Figure 17. Global Medical Heparin Capacity Market Share by Region, 2022 VS 2029
Figure 18. Global Medical Heparin Production Market Share & Forecast by Region, 2019-2030
Figure 19. Medical Heparin Industry Chain
Figure 20. Medical Heparin Procurement Model
Figure 21. Medical Heparin Sales Model
Figure 22. Medical Heparin Sales Channels, Direct Sales and Distribution
Figure 23. High Molecular Weight Heparin (HMWH)
Figure 24. Low Molecular Weight Heparin (LMWH)
Figure 25. By Molecular Weight, Global Medical Heparin Revenue, 2019-2030, US$ Million
Figure 26. By Molecular Weight, Global Medical Heparin Revenue Market Share, 2019-2030
Figure 27. By Molecular Weight, Global Medical Heparin Sales Volume, 2019-2030, (Tons)
Figure 28. By Molecular Weight, Global Medical Heparin Sales Volume Market Share, 2019-2030
Figure 29. By Molecular Weight, Global Medical Heparin Price, 2019-2030, (US$/Ton)
Figure 30. Treatment of Thrombotic Diseases
Figure 31. Postoperative Rehabilitation
Figure 32. Others
Figure 33. By Application, Global Medical Heparin Revenue, 2019-2030, US$ Million
Figure 34. By Application, Global Medical Heparin Revenue Market Share, 2019-2030
Figure 35. By Application, Global Medical Heparin Sales Volume, 2019-2030, (Tons)
Figure 36. By Application, Global Medical Heparin Sales Volume Market Share, 2019-2030
Figure 37. By Application, Global Medical Heparin Price, 2019-2030, (US$/Ton)
Figure 38. By Region, Global Medical Heparin Revenue Market Share, 2019-2030
Figure 39. By Region, Global Medical Heparin Sales Volume Market Share, 2019-2030
Figure 40. North America Medical Heparin Revenue & Forecasts, 2019-2030, US$ Million
Figure 41. By Country, North America Medical Heparin Revenue Market Share, 2022
Figure 42. Europe Medical Heparin Revenue & Forecasts, 2019-2030, US$ Million
Figure 43. By Country, Europe Medical Heparin Revenue Market Share, 2022
Figure 44. Asia Pacific Medical Heparin Revenue & Forecasts, 2019-2030, US$ Million
Figure 45. By Country/Region, Asia Pacific Medical Heparin Revenue Market Share, 2022
Figure 46. South America Medical Heparin Revenue & Forecasts, 2019-2030, US$ Million
Figure 47. By Country, South America Medical Heparin Revenue Market Share, 2022
Figure 48. Middle East & Africa Medical Heparin Revenue & Forecasts, 2019-2030, US$ Million
Figure 49. U.S. Medical Heparin Sales Volume, 2019-2030, (Tons)
Figure 50. By Company, U.S. Medical Heparin Market Share, 2022
Figure 51. By Molecular Weight, U.S. Medical Heparin Sales Volume Market Share, 2022 VS 2029
Figure 52. By Application, U.S. Medical Heparin Sales Volume Market Share, 2022 VS 2029
Figure 53. Europe Medical Heparin Sales Volume, 2019-2030, (Tons)
Figure 54. By Company, Europe Medical Heparin Market Share, 2022
Figure 55. By Molecular Weight, Europe Medical Heparin Sales Volume Market Share, 2022 VS 2029
Figure 56. By Application, Europe Medical Heparin Sales Volume Market Share, 2022 VS 2029
Figure 57. China Medical Heparin Sales Volume, 2019-2030, (Tons)
Figure 58. By Company, China Medical Heparin Market Share, 2022
Figure 59. By Molecular Weight, China Medical Heparin Sales Volume Market Share, 2022 VS 2029
Figure 60. By Application, China Medical Heparin Sales Volume Market Share, 2022 VS 2029
Figure 61. Japan Medical Heparin Sales Volume, 2019-2030, (Tons)
Figure 62. By Company, Japan Medical Heparin Market Share, 2022
Figure 63. By Molecular Weight, Japan Medical Heparin Sales Volume Market Share, 2022 VS 2029
Figure 64. By Application, Japan Medical Heparin Sales Volume Market Share, 2022 VS 2029
Figure 65. South Korea Medical Heparin Sales Volume, 2019-2030, (Tons)
Figure 66. By Company, South Korea Medical Heparin Market Share, 2022
Figure 67. By Molecular Weight, South Korea Medical Heparin Sales Volume Market Share, 2022 VS 2029
Figure 68. By Application, South Korea Medical Heparin Sales Volume Market Share, 2022 VS 2029
Figure 69. Southeast Asia Medical Heparin Sales Volume, 2019-2030, (Tons)
Figure 70. By Company, Southeast Asia Medical Heparin Market Share, 2022
Figure 71. By Molecular Weight, Southeast Asia Medical Heparin Sales Volume Market Share, 2022 VS 2029
Figure 72. By Application, Southeast Asia Medical Heparin Sales Volume Market Share, 2022 VS 2029
Figure 73. India Medical Heparin Sales Volume, 2019-2030, (Tons)
Figure 74. By Company, India Medical Heparin Market Share, 2022
Figure 75. By Molecular Weight, India Medical Heparin Sales Volume Market Share, 2022 VS 2029
Figure 76. By Application, India Medical Heparin Sales Volume Market Share, 2022 VS 2029
Figure 77. Middle East & Asia Medical Heparin Sales Volume, 2019-2030, (Tons)
Figure 78. By Company, Middle East & Asia Medical Heparin Market Share, 2022
Figure 79. By Molecular Weight, Middle East & Asia Medical Heparin Sales Volume Market Share, 2022 VS 2029
Figure 80. By Application, Middle East & Asia Medical Heparin Sales Volume Market Share, 2022 VS 2029
Figure 81. Research Methodology
Figure 82. Breakdown of Primary Interviews
Figure 83. Bottom-up Approaches
Figure 84. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|